Stock Analysis on Net

Edwards Lifesciences Corp. (NYSE:EW)

$22.49

This company has been moved to the archive! The financial data has not been updated since February 14, 2022.

Net Profit Margin
since 2005

Microsoft Excel

Calculation

Edwards Lifesciences Corp., net profit margin, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$ in thousands


The financial data reflects several key trends in the company's performance over the period from 2005 to 2021. Net sales demonstrate a consistent upward trajectory, increasing steadily from approximately $998 million in 2005 to over $5.2 billion in 2021. This indicates sustained revenue growth throughout the years.

Net income exhibits a general growth trend as well, albeit with some fluctuations. Starting at $79.3 million in 2005, net income rose gradually, with notable jumps in certain years. Significant increases are observed in 2009, reaching $229.1 million, and again in 2014 at $811.1 million, followed by a dip in 2015 and 2016, before rising sharply to $1.5 billion in 2021. These variations suggest periods of enhanced profitability possibly linked to operational improvements or market conditions.

The net profit margin percentage, which measures profitability relative to sales, follows a generally positive trend with some volatility. It begins at 7.95% in 2005, peaks at an exceptionally high 34.92% in 2014, then somewhat normalizes ranging between approximately 16% and 28% in the later years. The 2014 peak signifies an unusually high-profit efficiency during that year, while subsequent years maintain strong but more moderate margins, illustrating effective cost control and profitability management.

Revenue Growth
Net sales nearly quintupled over the period, indicating robust expansion in the company's market reach and/or product demand.
Profitability Trends
Net income growth aligns with sales increases but shows more variability, highlighting periods of either higher operational costs, investments, or one-time events impacting earnings.
Profit Margin Fluctuations
Profit margins vary significantly year-over-year, with a standout peak in 2014 suggesting an exceptional operational year. Overall margins remain strong, underscoring good profitability management despite fluctuations.

In summary, the data depicts a company that has progressively expanded its revenue base with improving profitability over the long term, despite some volatility in net income and profit margins. This suggests a resilient business model capable of sustaining growth and generating healthy returns on sales.


Comparison to Competitors

Edwards Lifesciences Corp., net profit margin, long-term trends, comparison to competitors

Microsoft Excel

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Sector (Health Care Equipment & Services)

Edwards Lifesciences Corp., net profit margin, long-term trends, comparison to sector (health care equipment & services)

Microsoft Excel

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Industry (Health Care)

Edwards Lifesciences Corp., net profit margin, long-term trends, comparison to industry (health care)

Microsoft Excel

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).